Rocket Lab’s Neutron Delay: What the Selloff Changes

Executive Summary

Rocket Lab has confirmed that Neutron’s inaugural launch is now expected in 2027. The company’s October 14 filing attributes the schedule change to continuing development and manufacturing-process improvements. Rocket Lab filing, Reuters.

RKLB closed October 15 at $55.25, down 6.64%. That is the latest completed-session reaction used here, rather than an October 16 live quotation. Stock Analysis, MarketBeat.

Our assessment: the setback increases execution risk and delays evidence supporting Neutron’s commercial promise. Rocket Lab’s existing operations give the bull case substance, but they cannot demonstrate that the new rocket’s manufacturing process is ready.

Why This Matters

Neutron is a reusable medium-lift vehicle intended to compete for larger commercial satellite, civil-space and national-security missions. Its significance extends beyond adding another rocket: successful service entry could broaden the missions Rocket Lab can address. Reuters.

Investors therefore face a timing and economics problem. More development work can mean more spending before commercial returns. Rocket Lab explicitly identifies that relationship in its annual risk disclosures. Annual filing.

The Thesis

The schedule history matters. By August, Rocket Lab was targeting delivery to the launch pad in Q4 2026 and warning that the remaining launch window depended on qualification and other critical tests. The latest announcement confirms the slippage that conditional language had already made possible. Quarterly filing, Reuters.

The investment question is whether Rocket Lab can demonstrate a repeatable manufacturing process while its established businesses improve the financial foundation supporting development. A revised calendar alone will provide less reassurance than completed tests.